Sculati Wealth Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Sculati Wealth Management's LLY Position: Q1 2026 in Review
Sculati Wealth Management increased its Eli Lilly (LLY) stake by 1.7% in Q1 2026, buying an estimated $40.6K and bringing the position to 2,366 shares worth $2.18M. The position accounts for 0.8% of the portfolio, ranked #39.
Sculati Wealth Management first reported a position in LLY in Q2 2021 and has held it in 20 quarters since. The position peaked at $2.5M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Sculati Wealth Management held 2,366 shares of Eli Lilly worth $2.18M as of Q1 2026.
- Sculati Wealth Management bought 40 Eli Lilly shares in Q1 2026, an estimated $40.6K.
- Eli Lilly made up 0.8% of Sculati Wealth Management's portfolio in Q1 2026, its #39 holding.
- Sculati Wealth Management first reported a position in Eli Lilly in Q2 2021 and has held it in 20 quarters since.
- Sculati Wealth Management's Eli Lilly position peaked at $2.5M in Q4 2025.
- 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Sculati Wealth Management's 13F filing for Q1 2026, filed 9 Apr 2026.